Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 556-562, February 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairchild, R. G.
Right arrow Articles by McNally, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairchild, R. G.
Right arrow Articles by McNally, W. P.

Chlorpromazine Distribution in Hamsters and Mice Bearing Transplantable Melanoma1

Ralph G. Fairchild2, Dennis Greenberg, Karen P. Watts, Samuel Packer, Harold L. Atkins, Prantika Som, Stephen J. Hannon, A. Bertrand Brill, Irwin Fand and William P. McNally

Brookhaven National Laboratory, Associated Universities, Inc., Upton, New York 11973 [R. G. F., D. G., K. P. W., S. P., H. L. A., P. S., S. J. H., A. B. B.], and Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, New York 11794 [I. F., W. P. M.]

Chlorpromazine (CPZ) distribution was measured in tissues of Syrian golden hamsters bearing Greene melanoma and in BALB/c mice bearing Harding-Passey melanoma. Distribution was evaluated as a function of time (0.5 to 14 days) and as a function of single and multiple doses (up to five) of from 5 to 50 mg CPZ per kg body weight. Routes of administration (i.p., i.v., p.o.) were compared. The physiological behavior of CPZ is of interest as it is used extensively as a tranquilizing drug (Thorazine). Further, since CPZ binds to the pigment melanin, the possibility exists of using CPZ to transport diagnostic or therapeutic agents to melanoma. It was found that, at 2 days postinjection, tumor/tissue concentration ratios exceeded 10 for metabolizing organs, such as liver, and 100 for "background" tissues, such as blood and muscle. Absolute concentrations of CPZ in tumor exceeding 100 µg CPZ per g tumor were obtained with both single and multiple doses. This selective high concentration in tumor would make CPZ an ideal vehicle for the transport of boron to tumor for use in neutron capture therapy via the 10B(n,{alpha})7Li reaction.

1 Work supported by National Cancer Institute Grant R01-CA22749 and United States Department of Energy Contract DE-AC02-76CH00016.

2 To whom requests for reprints should be addressed, at Medical Dept., Brookhaven National Laboratory, Upton, N. Y. 11973.

Received 3/30/81. Accepted 10/27/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.